Outsourcing

Thomas Page, PhD, is vice-president, Engineering at FUJIFILM Diosynth Biotechnologies.

Articles

A new facility type integrates next-generation mobile cleanroom systems.

Designing and Operating Flexible, High-Containment Vaccine Manufacturing

The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.

WuXi and Pall Establish Continuous MAb Manufacture

Alcami will manufacture clinical supply of the API for a drug candidate targeting various hematologics and solid cancers.

Alcami in API Manufacturing Pact with Solasia

As part of Recipharm’s ongoing initiative to improve profitability and competitiveness, a decision has been made to end operations in Stockholm and Höganäs.

Recipharm Reveals Plans to Discontinue Operations in Two Swedish Facilities

Almac Group will acquire BioClin Laboratories to expand Almac’s analytical service offerings. 

Almac Group to Acquire BioClin Laboratories

Capsugel announced on Oct. 31, 2017 that it expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products using liquid-filled hard capsule technology, at its Edinburgh facility in Scotland.

Capsugel Expands Clinical Trial Services at UK Manufacturing Facility

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.

CDMO Acquisitions Build Strategic Supplier Base

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Industry experts were honored for business, scientific, and social contributions.

Awards Recognize Industry Contributions

Catalent’s new Biologics & Specialty Drug Delivery unit will be led by Barry Littlejohn; Jonathan Arnold to lead Oral Drug Delivery.

Catalent Closes Cook Pharmica Acquisition; Defines New Business Units

The CDMO is investing £6 million into a new facility at its United Kingdom site to expand its milling, micronization, and solid form capabilities.


Contract Manufacturing Services